Electrophysiological assessment of the effect of intrathecal baclofen in dystonic children

被引:20
作者
Dachy, B
Dan, B
机构
[1] CHU Brugmann, Dept Rehabil Neurol Dis, B-1020 Brussels, Belgium
[2] Hop Univ Enfants Reine Fabiola, Dept Neurol, Brussels, Belgium
关键词
dystonia; intrathecal baclofen; H reflex; flexor reflex; child;
D O I
10.1016/j.clinph.2003.11.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the effect of intrathecal baclofen in a group of dystonic children using electrophysiological procedures previously validated in spastic children. Methods: Seven children (aged 2-16 years) with dystonia of various aetiologies (dyskinetic cerebral palsy, pantothenate kinase-associated neurodegeneration and Aicardi-Goutieres syndrome) underwent transcranial magnetic stimulation, H-reflex and flexor reflex studies before and after intrathecal injection of baclofen. The Barry-Albright Dystonia Scale (BADS) was used for clinical evaluation of dystonia. Results: Motor-evoked potentials, present in 2 of 5 patients before baclofen, were preserved after injection. Before baclofen, H reflex was present in 6 of 7 patients (mean H-max/M-max: 0.45 +/- 0.21). It was markedly reduced after the injection (mean H-max/M-max: 0.09 +/- 0.11) (P < 0.001). Area of flexor reflex significantly decreased after baclofen (P = 0.047), while threshold significantly increased (P = 0.01). No significant clinical improvement of the BADS scores was observed (P = 0.058). Conclusions: These electrophysiological procedures, previously demonstrated to quantify the action of intrathecal baclofen in spastic adults and children, also appear sensitive in dystonic children. The electrophysiological changes are consistent with primarily spinal sites of action of baclofen. They appear more sensitive than clinical evaluation. (C) 2003 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:774 / 778
页数:5
相关论文
共 25 条
[1]
Infusion of intrathecal baclofen for generalized dystonia in cerebral palsy [J].
Albright, AL ;
Barry, MJ ;
Painter, MJ ;
Shultz, B .
JOURNAL OF NEUROSURGERY, 1998, 88 (01) :73-76
[2]
Intrathecal baclofen in cerebral palsy movement disorders [J].
Albright, AL .
JOURNAL OF CHILD NEUROLOGY, 1996, 11 :S29-S35
[3]
Intrathecal baclofen for generalized dystonia [J].
Albright, AL ;
Barry, MJ ;
Shafron, DH ;
Ferson, SS .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2001, 43 (10) :652-657
[4]
Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up [J].
Azouvi, P ;
Mane, M ;
Thiebaut, JB ;
Denys, P ;
RemyNeris, O ;
Bussel, B .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1996, 77 (01) :35-39
[5]
Reliability and responsiveness of the Barry-Albright dystonia scale [J].
Barry, MJ ;
VanSwearingen, JM ;
Albright, AL .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 1999, 41 (06) :404-411
[6]
GABA-A AND GABA-B RECEPTOR-SITE DISTRIBUTION IN THE RAT CENTRAL-NERVOUS-SYSTEM [J].
BOWERY, NG ;
HUDSON, AL ;
PRICE, GW .
NEUROSCIENCE, 1987, 20 (02) :365-383
[7]
CAPADAY C, 1995, EXP BRAIN RES, V104, P287
[8]
Electrophysiological assessment of the effect of intrathecal baclofen in spastic children [J].
Dachy, B ;
Dan, B .
CLINICAL NEUROPHYSIOLOGY, 2002, 113 (03) :336-340
[10]
Use of intrathecal baclofen in the treatment of patients with dystonia [J].
Ford, B ;
Greene, P ;
Louis, ED ;
Petzinger, G ;
Bressman, SB ;
Goodman, R ;
Brin, MF ;
Sadiq, S ;
Fahn, S .
ARCHIVES OF NEUROLOGY, 1996, 53 (12) :1241-1246